CSE:AYR.A - Post Discussion
Post by
retiredcf on Dec 15, 2021 6:35am
Canaccord 2022 Top Picks
Solid execution, an acquisitive 2021 and overall market growth should lead to a banner 2022
Investment recommendation
Although valuations of US multi-state operators (MSOs) faced notable pressure for most of 2021, we believe the sector continues to see positive regulatory tailwinds (at both the state and federal level), strong underlying fundamentals from many of the leading operators, and anticipated attractive near-term sector growth as new US markets continue to legalize and implement new cannabis regimes. After what we consider to
be strong execution in 2021, inclusive of a variety of strategic acquisitions that saw the company increase its national exposure to many of the leading US markets, we are introducing Ayr Wellness as our Top Pick. We reiterate our C$62 PT and BUY rating.
Be the first to comment on this post